Jan van Gijn

Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480] (2008)

Den Hertog, Heleen M, Worp, H Bart, Algra, Ale, Kappelle, L Jaap, Van Gijn, Jan, ...

Abstract Background The Paracetamol (Acetaminophen) In Stroke (PAIS) study is a phase III multicenter, double blind, randomized, placebo-controlled clinical trial of high-dose acetaminophen in...

Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET). Protocol for a randomised controlled trial of decompressive surgery in space-occupying hemispheric infarction (2006)

Hofmeijer, Jeannette, Amelink, G Johan, Algra, Ale, Van Gijn, Jan, Macleod, Malcolm R, Kappelle, L Jaap, ...

Abstract Background Patients with a hemispheric infarct and massive space-occupying brain oedema have a poor prognosis. Despite maximal conservative treatment, the case fatality rate may be as high...

PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN 74418480] (2005)

Van Breda, Eric J, Van Der Worp, H Bart, Algra, Ale, Kappelle, L Jaap, Van Gijn, Jan, ...

Abstract Background In patients with acute stroke, increased body temperature is associated with large lesion volumes, high case fatality, and poor functional outcome. A 1°C increase in body...

Is clopidogrel superior to aspirin in secondary prevention of vascular disease? (2000)

Algra, Ale, Van Gijn, Jan

Abstract The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel...

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?

Algra, Ale, Van Gijn, Jan

The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus...

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?

Algra, Ale, Van Gijn, Jan

The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus...